Cin Nasara a Lymphoma tare da Maganin CAR-T Biyu

Wata mata mai shekaru 61, wacce ta sha fama da jiyya daban-daban don maganin ciwon daji mai yaduwa Lymphoma na B-Cell, ciki har da zagayowar chemotherapy guda bakwai, maganin CAR-T, da kuma zagaye da dama na haɗin chemotherapy da radiation na PD-1, ta sami kanta a wani mawuyacin hali. Duk da ƙoƙarinta, yanayinta bai nuna wani ci gaba ba har sai da ta isa BIOOCUS don samun kulawa ta musamman.

A farkon shekarar 2021, yayin da cutar sankarar lymphatic ke ci gaba da yaduwa cikin sauri tare da haifar da mummunan raunukan fata da kumburi, yanayin majiyyacin ya bayyana da muni. A ƙarƙashin kulawar ƙungiyar da ta keɓe a BIOOCUS, ta fara wani sabon tafiya na magani. Bayan jiyya ta farko, yanayinta ya daidaita, wanda ya haifar da tattarawa da haɓaka ƙwayoyin lymphatic nata don maganin ƙwayoyin CD19/CD22 CAR-T.

A ranar 19 ga Fabrairu, 2021, an yi mata allurar ƙwayoyin CAR-T guda biyu. Duk da cewa ta fuskanci illolin da za a iya shawo kansu, gwajin PET-CT da aka yi daga baya ya nuna babban ci gaba. Zuwa watan Maris, ta sami kusan cikakkiyar sauƙi, wanda hakan ya nuna wani sauyi a yaƙinta da cutar kansa.

Yanzu, shekaru uku bayan maganin CAR-T, tana raba labarin murmurewarta a Huɗu a lokacin hutun ƙarshe Lymphoma na China Taron Marasa Lafiya, wanda ke ƙarfafa wasu da ke fuskantar irin waɗannan ƙalubale. Tafiyarta ta nuna ci gaban da aka samu a fannin magungunan CAR-T da kuma muhimmiyar rawar da maganin da aka keɓance ke takawa wajen magance matsalolin lymphoma masu rikitarwa.

Godiya ga cikakken kulawar da ake bayarwa a BIOOCUS, ta ci gaba da bunƙasa, tana mai jaddada muhimmancin magunguna masu inganci da kuma goyon bayan ƙwararrun ma'aikatan kiwon lafiya masu himma wajen shawo kan cutar kansa.